147 related articles for article (PubMed ID: 38375764)
1. BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma.
Dixon AJ; Kyrgidis A; Sladden M; Nirenberg A; Steinman HK; Smith H; Zachary CB; Anderson S; Leiter-Stöppke U; Longo C; Apalla Z
J Eur Acad Dermatol Venereol; 2024 Feb; ():. PubMed ID: 38375764
[No Abstract] [Full Text] [Related]
2. A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.
Damude S; Wevers KP; Murali R; Kruijff S; Hoekstra HJ; Bastiaannet E
Eur J Surg Oncol; 2017 Sep; 43(9):1753-1759. PubMed ID: 28797756
[TBL] [Abstract][Full Text] [Related]
3. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF
J Surg Oncol; 2011 Sep; 104(4):379-85. PubMed ID: 21858832
[TBL] [Abstract][Full Text] [Related]
4. Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
Robinson EM; Rosenbaum BE; Zhang Y; Rogers R; Tchack J; Berman RS; Darvishian F; Osman I; Shapiro RL; Shao Y; Polsky D
J Surg Oncol; 2018 Jul; 118(1):150-156. PubMed ID: 29878361
[TBL] [Abstract][Full Text] [Related]
5. Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma.
van Akkooi ACJ; Schadendorf D; Eggermont AMM
Eur J Cancer; 2023 Mar; 182():163-169. PubMed ID: 36681612
[TBL] [Abstract][Full Text] [Related]
6. Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma.
Meyer S; Buser L; Haferkamp S; Berneburg M; Maisch T; Klinkhammer-Schalke M; Pauer A; Vogt T; Garbe C
Eur J Cancer; 2023 Mar; 182():77-86. PubMed ID: 36753835
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma.
Jain P; Finger PT; Damato B; Coupland SE; Heimann H; Kenawy N; Brouwer NJ; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
JAMA Ophthalmol; 2019 Aug; 137(8):905-911. PubMed ID: 31169891
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based staging system for cutaneous melanoma.
Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
[TBL] [Abstract][Full Text] [Related]
9. A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging.
Brunner G; Heinecke A; Falk TM; Ertas B; Blödorn-Schlicht N; Schulze HJ; Suter L; Atzpodien J; Berking C
JNCI Cancer Spectr; 2018 Jul; 2(3):pky032. PubMed ID: 31360859
[TBL] [Abstract][Full Text] [Related]
10. Melanoma: Staging and Follow-Up.
Papageorgiou C; Apalla Z; Manoli SM; Lallas K; Vakirlis E; Lallas A
Dermatol Pract Concept; 2021 Jul; 11(Suppl 1):e2021162S. PubMed ID: 34447611
[TBL] [Abstract][Full Text] [Related]
11. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Chin K; Finger PT; Kurli M; Tena LB; Reddy S
Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
[TBL] [Abstract][Full Text] [Related]
12. Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.
Teterycz P; Ługowska I; Koseła-Paterczyk H; Rutkowski P
World J Surg Oncol; 2019 Jul; 17(1):129. PubMed ID: 31345228
[TBL] [Abstract][Full Text] [Related]
13. A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma.
Zhang C; Dang D; Wang Y; Cong X
Front Oncol; 2021; 11():593587. PubMed ID: 33868993
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
Zeng Q; Yao Y; Zhao M
BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
Gerami P; Cook RW; Russell MC; Wilkinson J; Amaria RN; Gonzalez R; Lyle S; Jackson GL; Greisinger AJ; Johnson CE; Oelschlager KM; Stone JF; Maetzold DJ; Ferris LK; Wayne JD; Cooper C; Obregon R; Delman KA; Lawson D
J Am Acad Dermatol; 2015 May; 72(5):780-5.e3. PubMed ID: 25748297
[TBL] [Abstract][Full Text] [Related]
16. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged >50 with advanced melanoma.
Xi Q; Lu X; Zhang J; Wang D; Sun Y; Chen H
Front Oncol; 2023; 13():1166877. PubMed ID: 37519813
[TBL] [Abstract][Full Text] [Related]
17. Metastatic uveal melanoma: The final frontier.
Rantala ES; Hernberg MM; Piperno-Neumann S; Grossniklaus HE; Kivelä TT
Prog Retin Eye Res; 2022 Sep; 90():101041. PubMed ID: 34999237
[TBL] [Abstract][Full Text] [Related]
18. Melanoma staging and sentinel lymph node biopsy.
Forsea AM
Acta Dermatovenerol Croat; 2010; 18(4):279-88. PubMed ID: 21251448
[TBL] [Abstract][Full Text] [Related]
19. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
[TBL] [Abstract][Full Text] [Related]
20. Principles of Melanoma Staging.
Boland GM; Gershenwald JE
Cancer Treat Res; 2016; 167():131-48. PubMed ID: 26601861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
